From: Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) – a study protocol
Men (cancers excluded)
Women (cancers excluded)
Non-melanoma skin cancer
Breast
Prostate
Ovarian
Male genital organs
Endometrial
Female genital organs